You are viewing: Canada Radiotherapy Market analysis
Part of: Radiotherapy Market (Global)

The Canada Radiotherapy Market was valued at $1856.1 Million in 2026 and projected to reach to $2154.3 Million by 2031, representing a compound annual growth rate of CAGR 3.9%. Canada's radiotherapy market is positioned for steady growth through 2031, supported by an aging population with rising cancer prevalence and provincial government commitments to oncology infrastructure modernization.

Canada Radiotherapy Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Radiotherapy Market Trends and Insights

  • This steady expansion reflects Canada's aging population, rising cancer incidence, and increasing adoption of advanced radiation therapy technologies across provincial healthcare systems.
  • Canada's investment in oncology infrastructure and government-funded treatment programs continue to support market development. The Canadian radiotherapy sector benefits from strong healthcare infrastructure and equitable access through provincial health authorities.
  • Canada's market growth, while moderate compared to global trends, is driven by technological advancements in precision medicine, growing demand for non-invasive treatment options, and expanded patient access to modern linear accelerators and brachytherapy systems.
  • Between 2026 and 2031, Canada is expected to see incremental capacity additions and modernization of existing treatment centers. Canada's regulatory environment and emphasis on evidence-based oncology care position the country as a stable market for radiotherapy innovation.
  • Canada continues to integrate emerging modalities such as intensity-modulated radiation therapy (IMRT) and image-guided radiotherapy (IGRT) into clinical practice, supporting the projected market expansion through 2031..

Key Market Statistics

  • CAGR (2026-2031) CAGR 3.9%
  • Market Size, 2026 ~USD 1856.1 Million
  • Forecast, 2031 ~USD 2154.3 Million
  • Country Canada

Canada Radiotherapy Market Overview

Market Size & Growth :

Canada's radiotherapy market is valued at $1,856.1 million in 2026 and is projected to reach $2,154.3 million by 2031, with a CAGR of 3.9%, reflecting steady expansion driven by healthcare infrastructure investments.

Aging Population Impact :

Canada's demographic shift toward an older population is driving increased cancer incidence rates, creating sustained demand for advanced radiotherapy treatments across provincial healthcare systems.

Technology Adoption :

Canadian healthcare providers are increasingly adopting advanced radiation therapy technologies including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic body radiotherapy (SBRT).

Provincial Healthcare Integration :

Radiotherapy services are integrated within Canada's publicly funded provincial healthcare systems, with coordinated oncology infrastructure development supporting equitable access across regions.

Canada Radiotherapy Market Dynamics

  • Healthcare providers across provinces are investing in state-of-the-art radiation therapy equipment and training, enhancing treatment capabilities and patient outcomes.
  • The market will benefit from increased adoption of precision medicine approaches and advanced imaging technologies that improve treatment planning and delivery accuracy. Key growth drivers include expanding cancer screening programs, improved early detection rates, and growing patient awareness of radiotherapy benefits.
  • Public healthcare funding initiatives and partnerships between provincial health authorities and private medical device manufacturers will accelerate technology deployment.
  • However, market growth remains moderate compared to global rates, reflecting Canada's mature healthcare system and measured adoption cycles within publicly funded provincial frameworks..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Canada's radiotherapy market is valued at $1,856.1 million in 2026 and will reach $2,154.3 million by 2031, growing at a 3.9% CAGR.
    • Canada's aging population and rising cancer prevalence are primary drivers of steady market expansion through the forecast period.
    • Canada's publicly funded healthcare system ensures broad patient access to radiotherapy, supporting consistent demand across provinces.
    • Canada is adopting advanced modalities including IMRT, IGRT, and precision oncology technologies to enhance treatment outcomes.

    Radiotherapy Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment ASIA PACIFIC (Application)
    Forecast Period 2026–2031
    Growth Rate CAGR of 6% from 2026 to 2031
    Largest Segment OTHER EBRT APPLICATIONS (Procedure)
    Market Size Base Year (Billions) ~USD 7.98 (2026)
    Revenue Forecast (Billions) ~USD 10.68 (2031)
    Segments Covered Type, System Type, Application, Procedure, End User, Technology

    Canada Radiotherapy Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Type

    • 3D Conformal Radiotherapy
    • Afterloaders
    • Applicators
    • Breast Cancer
    • Cervical Cancer
    • Colorectal Cancer
    • Conventional Cobalt-60 Teletherapy
    • Conventional Cobalt-60 Teletherapy Units
    • Conventional Linacs
    • Cyberknife
    • Cyclotrons
    • Electron-Emitting High-Energy Linear Accelerators (Linac)
    • Gamma Knife
    • Gynecological Cancer
    • Hdr Brachytherapy
    • Head & Neck Cancer
    • Igrt
    • Imrt
    • Iort Systems
    • Ldr Brachytherapy
    • Linacs
    • Lung Cancer
    • Mri Linacs
    • Other Ebrt Applications
    • Other Ebrt Procedures
    • Other External Beam Radiotherapy Applications
    • Other Ibrt/ Brachytherapy Applications
    • Other Internal Beam Radiotherapy/
    • Particle Therapy
    • Pdr Brachytherapy
    • Penile Cancer
    • Prostate Cancer
    • Proton Therapy Systems
    • Seeds
    • Srt
    • Stereotactic Advanced Electron/Cobalt-60 Linacs
    • Synchrocyclotrons
    • Synchrotrons
    • Tomotherapy

    By System Type

    • Cyclotrons
    • Synchrocyclotrons
    • Synchrotrons

    By Application

    • Ebrt Applications
    • Ibrt/Brachytherapy Applications

    By Procedure

    • Ebrt
    • External Beam Radiotherapy
    • Ibrt/ Brachytherapy
    • Internal Beam Radiotherapy/Brachytherapy

    By End User

    • Hospitals
    • Hospitals And Clinics
    • Independent Radiotherapy Centers

    By Technology

    • External Beam Radiation Therapy
    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/Brachytherapy
    • Internal Radiation Therapy

    Target Audience

    • Medical Device Manufacturers : Radiotherapy equipment and software vendors need Canada-specific market data to develop localized go-to-market strategies, navigate provincial procurement processes, and identify partnership opportunities with healthcare providers.
    • Healthcare Providers & Hospital Networks : Canadian cancer centers and provincial health authorities require market intelligence on technology trends, competitive offerings, and investment benchmarks to optimize radiotherapy service delivery and capital planning.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Canadian healthcare need detailed market sizing, growth forecasts, and competitive dynamics to assess investment returns and identify acquisition targets in the radiotherapy sector.
    • Healthcare Consultants & Advisors : Strategy consultants supporting healthcare organizations and medical device companies require Canada-specific market data to develop business cases, competitive analyses, and expansion recommendations.
    • Government & Policy Makers : Provincial health ministries and federal health agencies need market insights to inform oncology infrastructure planning, funding allocation, and healthcare policy development for radiotherapy services.

    Key Companies in the Canada Radiotherapy Market

    CompanyHQOwnershipStrongest segments
    ADVANCED MEDICAL ISOTOPE CORPORATIONUnited StatesPublic CompanyIsoPet (veterinary radionuclide therapy),RadioGel and human oncology platforms,PLGA-g-PEG and PrecisionGel polymer platforms,
    UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
    BECTON DICKINSON AND COUnited StatesPublic CompanyMedical Essentials (syringes, needles, catheters, IV sets, sharps disposal),Connected Care & Medication Management (infusion, dispensing, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    UNITED IMAGING HEALTHCARE CO., LTD.ChinaPublic CompanyCT and MRI systems,Molecular imaging (PET/CT, SPECT),Radiotherapy systems (uRT-linac and ecosystem),
    GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
    SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
    ELEKTASwedenPublic CompanyLinear accelerators and MR-Linac (Unity, Evo, Versa HD, Harmony, Infinity),Stereotactic radiosurgery (Elekta Esprit gamma knife and neurosurgery systems),Brachytherapy solutions (Elekta Studio, ImagingRing, Oncentra Brachy, Venezia, Flexitron, Geneva, Xoft Axxent),
    ACCURAY INCORPORATEDUnited StatesPublic CompanyCyberKnife platform (systems + upgrades + related services),TomoTherapy / Radixact platform (systems + upgrades + related services),Software & data management (iDMS, Accuray Precision, other planning/data tools),
    HITACHI HIGH-TECH CORPORATIONJapanPrivate CompanyAnalytical & Medical Solutions (microscopes, clinical analyzers, chromatography, spectroscopy),Nano-Technology Solutions (dry etch, CD-SEM, wafer inspection, FIB),Industrial Solutions and ICT (industrial infrastructure, energy, control systems, ICT/IoT),
    SUMITOMO HEAVY INDUSTRIES, LTD.JapanPublic CompanyMechatronics (gearmotors, drives, precision positioning, cryogenic equipment),Industrial Machinery (plastics, film forming, semiconductor, medical, defense),Logistics & Construction (excavators, cranes, road and logistics systems),
    MEVION MEDICAL SYSTEMSUnited StatesPrivate CompanyMevion S250i with Hyperscan and Adaptive Aperture,Mevion S250 series (base compact systems),Mevion S250MX multi-room solution,
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy (systems and devices),Connected Care & Monitoring (incl. enterprise informatics),
    SHINVA MEDICAL INSTRUMENT CO., LTD.ChinaPublic CompanyMedical Device Products (infection control, OR integration, radiotherapy, surgical instruments, IVD, dialysis, orthopedic implants),Pharmaceutical Equipment Products (large/small volume injection lines, BFS, freeze dryers, aseptic systems),Medical Trade Products,

    ADVANCED MEDICAL ISOTOPE CORPORATION

    Advanced Medical Isotope Corporation is a publicly traded company established in 1994 that operates in the medical isotope sector in the United States.

    UNILABS

    Unilabs is a Swiss private company founded in 1987 with 1,897 employees providing laboratory and diagnostic services.

    BECTON DICKINSON AND CO

    Becton Dickinson and Co is a publicly traded medical technology company founded in 1897 with 72,000 employees, headquartered in the United States.

    UNITED IMAGING HEALTHCARE CO., LTD.

    United Imaging Healthcare Co., Ltd. is a Chinese public company founded in 2011 with 8,703 employees specializing in medical imaging technology.

    GE HEALTHCARE

    GE Healthcare is a publicly traded healthcare company established in 2022 with 54,000 employees based in the United States.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees operating in the healthcare technology sector.

    ELEKTA

    Elekta is a Swedish public company founded in 1972 with 3,704 employees specializing in radiation therapy and radiosurgery solutions.

    ACCURAY INCORPORATED

    Accuray Incorporated is a publicly traded medical device company founded in 1990 with 990 employees based in the United States.

    HITACHI HIGH-TECH CORPORATION

    Hitachi High-Tech Corporation is a Japanese private company founded in 1947 with 11,482 employees providing advanced technology solutions.

    SUMITOMO HEAVY INDUSTRIES, LTD.

    Sumitomo Heavy Industries, Ltd. is a Japanese public company founded in 1888 with 25,123 employees operating across multiple industrial sectors.

    MEVION MEDICAL SYSTEMS

    Mevion Medical Systems is a private medical device company established in 2004 with 165 employees operating in the United States.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees operating in healthcare, consumer, and industrial sectors.

    SHINVA MEDICAL INSTRUMENT CO., LTD.

    Shinva Medical Instrument Co., Ltd. is a Chinese public company founded in 1943 with 7,982 employees specializing in medical instruments.

    Reasons to Buy this Report

    • Provincial Market Segmentation : Gain detailed insights into radiotherapy adoption rates and infrastructure investments across Canada's 10 provinces and 3 territories, enabling targeted market entry and partnership strategies.
    • Healthcare System Dynamics : Understand how Canada's publicly funded provincial healthcare model influences radiotherapy procurement, reimbursement policies, and technology adoption timelines for strategic planning.
    • Competitive Landscape Analysis : Identify key radiotherapy equipment suppliers, treatment centers, and emerging competitors operating in Canada's market, with insights into market share and positioning strategies.
    • Demographic & Clinical Trends : Access data on cancer incidence projections, aging population statistics, and treatment modality preferences specific to Canada to forecast demand and align product development.
    • Investment & Growth Opportunities : Discover high-potential segments, underserved regions, and emerging technologies gaining traction in Canadian healthcare systems to identify expansion and partnership opportunities.

    Frequently asked questions

    What is the current size of Canada's radiotherapy market?

    Canada's radiotherapy market is estimated at $1,856.1 million in 2026 and is expected to grow to $2,154.3 million by 2031.

    What is the projected growth rate for Canada's radiotherapy market?

    Canada's radiotherapy market is projected to grow at a compound annual growth rate (CAGR) of 3.9% from 2026 to 2031.

    What factors are driving growth in Canada's radiotherapy market?

    Key drivers include Canada's aging population, rising cancer incidence, adoption of advanced radiation technologies, and government-funded healthcare access across provinces.

    How does Canada's healthcare system support radiotherapy access?

    Canada's publicly funded provincial healthcare systems ensure equitable access to radiotherapy services, supporting consistent patient demand and market stability.

    What advanced technologies is Canada adopting in radiotherapy?

    Canada is increasingly integrating intensity-modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), and precision oncology technologies into clinical practice.

    RESEARCH METHODOLOGY

    This study involved the extensive use of both primary and secondary sources. Exhaustive secondary research was done to collect information on the radiotherapy industry. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the radiotherapy market's segments and subsegments. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key players' strategies.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    The market for companies offering radiotherapy products is derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem and rating them by performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. Secondary research was used to obtain critical information on the industry's value chain, the total pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the radiotherapy market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    After the complete market engineering (calculations for market statistics, market breakdown, market estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at fill primary research was also conducted to identify the segmentation types industry trends competitive landscape of radiotherapy offered by various market players and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends and key players strategies.

    In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data regulation methods, to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted across the entire market engineering process to identify key insights throughout the report.

    A breakdown of the primary respondents is provided below:

    Radiotherapy Market
 Size, and Share

    Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various market segments.

    To determine the size of the global radiotherapy market, revenue share analysis was employed with the leading players. In this case, key market players have been identified, and their radiotherapy product business revenues have been determined using insights gathered during the primary and secondary research phases. Secondary research included the study of top market players' annual and financial reports. On the other hand, primary research included in-depth interviews with key opinion leaders, particularly chief executive officers, directors, and key marketing executives.

    Radiotherapy Market : Top-Down and Bottom-Up Approach

    Radiotherapy Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the overall market size through the market size estimation process described above, the global radiotherapy market was segmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the radiotherapy market was validated using both top-down and bottom-up approaches.

    Market Definition

    The radiotherapy market includes a range of products, solutions, technologies, and services that utilize high-energy radiation for therapeutic purposes. This encompasses various types of radiation, such as X-ray, gamma, electron, and particle radiation. The technologies segment of radiotherapy features systems designed to treat diseases, primarily cancer. This includes external beam radiotherapy methods like LINAC, MRI-LINAC, and cobalt-60 teletherapy. Additionally, internal radiotherapy solutions, commonly known as brachytherapy, are also part of this market segment. Other components of the radiotherapy market include software for imaging and treatment planning. Furthermore, the market provides maintenance and training services related to radiotherapy technologies.

    Key Stakeholders

    • Radiotherapy product manufacturing companies
    • Distributors, suppliers, and commercial service providers
    • Healthcare service providers
    • Clinical research organizations (CROs)
    • Radiotherapy service providers
    • Radiotherapy product distributors
    • Medical research laboratories
    • Cancer care centers
    • Cancer research organizations
    • Academic medical centers and universities
    • Market research and consulting firms

    Report Objectives

    • To define, describe, and forecast the radiotherapy market based on offering, technology, application, procedure, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global radiotherapy market (drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micromarkets for individual growth trends, prospects, and contributions to the global radiotherapy market
    • To analyze key growth opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Arica)
    • To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies
    • To track and analyze the competitive developments undertaken in the global radiotherapy market, such as agreements, expansions, and product launches

    Available customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top 16 companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to 15)

    Geographic Analysis

    • Further breakdown of the Rest of Europe radiotherapy market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
    • Further breakdown of the Rest of Asia Pacific radiotherapy market into Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other APAC countries
    • Further breakdown of the Rest of Latin America radiotherapy market into Argentina, Chile, Peru, and Colombia, among others

    Get the Full Radiotherapy Market Report

    Full forecast, segment splits, and company analysis for all Radiotherapy Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status